Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used for the regular maintenance treatment of reversible obstructive airways diseases. It is a vital tool for patients suffering from asthma, providing consistent management to keep airways open and reduce inflammation. The formulation is particularly suitable for patients already on effective maintenance doses of long-acting beta-agonists and inhaled corticosteroids. It also serves individuals who remain symptomatic on their current inhaled steroid therapy, providing the extra support needed for stability. Beyond asthma, Saltra is indicated for the regular treatment of Chronic Obstructive Pulmonary Disease (COPD). This includes serious chronic conditions like bronchitis and emphysema where airflow is significantly restricted. The inhaler works by delivering medication directly to the lung tissue to reduce swelling and relax the muscles surrounding the airways. Regular daily use helps decrease the frequency and severity of asthma attacks and prevents the daily breathlessness associated with COPD. The HFA delivery system ensures that a precise and consistent dose reaches the lower respiratory tract with every use. It is a foundational therapy for maintaining long-term lung health and physical activity levels.

• Maintenance treatment for asthma and Chronic Obstructive Pulmonary Disease (COPD).
• Combines anti-inflammatory and bronchodilator actions for open airways.
• Reduces the frequency of asthma attacks and COPD flare-ups.
• Available as: Inhaler 25mcg + 125mcg and 25mcg + 250mcg.